Validated AI Conference

Cambridge, MA

•

April 9, 2026

Validated AI Conference

Learn how leading teams validate AI without slowing development

Validated AI was a free half-day conference on validating AI in regulated environments, held April 9, 2026 in Cambridge, MA and online. Leading teams shared how they are integrating AI into products and development processes without sacrificing compliance or speed, through expert-led sessions and candid peer discussions. Watch the full event on demand below.

Topics

Industry Leaders Attending

What's in Store?

Insights and strategies to accelerate AI adoption in regulated industries

Compliance Frameworks for AI Systems

Discover validation frameworks for AI systems in regulated environments. Learn how to implement FDA guidance on AI/ML validation, create audit-ready documentation for AI, and maintain end-to-end traceability.

Pilot to Production: Real AI Validation Journeys

Hear real-world case studies of how companies validated AI in production under IEC 62304 and ISO 14971. Learn documentation strategies that passed audits, governance frameworks that worked, and honest lessons learned from pilot to production.

Validating AI Workflows in Practice

Learn practical frameworks for validating AI in regulated workflows—from automated testing to change impact analysis. Explore how to implement human-in-the-loop controls, build audit trails that satisfy FDA requirements, and incorporate AI in regulated environments.

Meet the speakers

Erez Kaminski

Founder & CEO

| Ketryx

View bio

Mike Monovoukas

CEO & Co-Founder

| AcuityMD

View bio

Jenn Dixon

Former Director, AI Quality & Regulatory

| Ketryx

View bio

Don O'Neill

VP of Engineering

| Sequel Medtech

View bio

Mary Brook Delano

Chief Business Officer

| Ketryx

View bio

Norm Lord

Vice President, Digital Products

| Revvity

View bio

Gabriel Pascualy

Head of Product

| Ketryx

View bio

Tim Brodeur

VP, Success & Delivery

| Ketryx

View bio

Scott Rosen

Partner

| Transformation Capital

View bio

Prachee Chaturvedi

Director, Digital & AI Product R&D

| Sanofi

View bio

Joy Foster

Head of Lab and Clinical Operations Platform Engineering

| GeneDx

View bio

Michelle Vuolo

Head of Quality

| Tulip

View bio

Behnam Partopour

Principal Scientist

| Sartorius

View bio

Rajesh Misra

Principal Life Sciences Quality and Regulatory

| KPMG

View bio

Varun Ramdevan

External Innovation and Partnerships, Enterprise Technology

| Johnson & Johnson

View bio

Agenda

12:00 – 1:05 PM

Registration & Networking / Building Safety-Critical AI

Check in and connect with fellow attendees. Doctors are diagnosing with AI, autonomous vehicles are navigating city streets, and labs are compressing months of experiments into days. This isn't a vision of where things are headed. This transition is happening right now, all over the world. This session explains what validated AI is making possible, and how to take a risk-based approach to building safety-critical AI systems.

Erez Kaminski

Founder & CEO

Ketryx

1:05 – 2:00 PM

AI Adoption in Life Sciences: What's Working

The question is no longer whether to adopt AI. It's how companies are putting it to work in practice. This session explores how life sciences organizations are deploying AI across imaging, patient monitoring, clinical development, and commercial functions, what's driving adoption, and what it takes to operationalize these initiatives at scale.

Scott Rosen

Partner

Transformation Capital

Mike Monovoukas

CEO & Co-Founder

AcuityMD

Erez Kaminski

Founder & CEO

Ketryx

2:10 – 2:45 PM

Accelerating AI-Native Product Development

AI coding tools like Claude Code and Cursor are already in your engineers' hands. This session covers what changes when AI is writing production code and hardware in a regulated environment: how code review practices need to evolve, where CI/CD needs guardrails, and how quality teams need to operate when the way software gets built has fundamentally changed.

Gabriel Pascualy

Head of Product

Ketryx

Don O’Neill

VP of Engineering

Sequel Medtech

Prachee Chaturvedi

Director, Digital & AI Product R&D

Sanofi

2:45 – 3:20 PM

AI Maturity Across the SDLC: From Design to Deployment

AI is now a standard part of how software is built, but in regulated environments, every change still needs to be understood, validated, and tied to intended use. This session explores how teams progress along an AI maturity curve, from deterministic processes to AI-assisted development, and how they accelerate from a mature foundation without losing control. You'll hear how leading teams connect risk, requirements, and validation as change becomes continuous, so they can move faster while staying audit-ready.

Jenn Dixon

Former Director, AI Quality & Regulatory

Ketryx

Joy Foster

Head of Lab and Clinical Operations Platform Engineering

GeneDx

3:20 – 3:45 PM

Networking Break

Recharge and connect with fellow attendees.

3:45 – 4:20 PM

Making AI Work in Life Science

AI is managing batch records, flagging deviations, and monitoring processes in real time. This session explains what AI actually looks like inside GxP operations right now, what it takes to get there, and what the industry can learn from organizations that have already made the leap from concept to compliant deployment.

Michelle Vuolo

Head of Quality

Tulip

Behnam Partopour

Principal Scientist

Sartorius

Tim Brodeur

VP, Success & Delivery

Ketryx

4:20 – 5:00 PM

Getting AI Past the Pilot

Whether it's compliant handling, change impact assessment, or regulatory document generation, the gap between proof of concept and production is familiar to anyone trying to accelerate AI adoption in their organization. This session offers advice to close that gap, showing what it takes to build coalitions, make the case, and create the conditions where AI becomes how work gets done.

Norm Lord

Vice President, Digital Products

Revvity

Rajesh Misra

Principal Life Sciences Quality and Regulatory

KPMG

Varun Ramdevan

External Innovation and Partnerships, Enterprise Technology

Johnson & Johnson

Mary Brook Delano

Chief Business Officer

Ketryx

5:00 – 6:15 PM

Closing Remarks / Cocktail Hour & Networking

Wind down with drinks, bites, and meaningful conversations.

Erez Kaminski

Founder & CEO

Ketryx

Venue

The Engine is a venture firm built by MIT that invests in founders solving the world's toughest problems through breakthrough science and engineering.

The Engine by MIT, 750 Main St, Cambridge, MA 02139

Get directions

Watch On Demand

Submit your details to get access to the recording of the full event.